Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20751 - 20775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cyclophosphamide	Approved Investigational	MAOA	4128	upregulated	Cyclophosphamide results in increased expression of MAOA mRNA	Xp11.3	A21865
Cyclophosphamide	Approved Investigational	MARCKS	4082	upregulated	Cyclophosphamide results in increased expression of MARCKS mRNA	6q21	A21865
Cyclophosphamide	Approved Investigational	MDFIC	29969	downregulated	Cyclophosphamide results in decreased expression of MDFIC mRNA	7q31.1-q31.2	A21865
Cyclophosphamide	Approved Investigational	MGMT	4255	downregulated	Cyclophosphamide results in decreased expression of MGMT mRNA	10q26.3	A21865
Cyclophosphamide	Approved Investigational	MR1	3140	upregulated	Cyclophosphamide results in increased expression of MR1 mRNA	1q25.3	A21863
Cyclophosphamide	Approved Investigational	MS4A3	932	downregulated	Cyclophosphamide results in decreased expression of MS4A3 mRNA	11q12.1	A21865
Cyclophosphamide	Approved Investigational	MTHFD2	10797	downregulated	Cyclophosphamide metabolite results in decreased expression of MTHFD2 mRNA	2p13.1	A20727
Cyclophosphamide	Approved Investigational	MX2	4600	downregulated	Cyclophosphamide results in decreased expression of MX2 mRNA	21q22.3	A21865
Cyclophosphamide	Approved Investigational	NANOS1	340719	upregulated	Cyclophosphamide metabolite results in increased expression of NANOS1 mRNA	10q26.11	A20727
Cyclophosphamide	Approved Investigational	NCOA7	135112	downregulated	Cyclophosphamide metabolite results in decreased expression of NCOA7 mRNA	6q22.31-q22.32	A20727
Cyclophosphamide	Approved Investigational	NETO2	81831	upregulated	Cyclophosphamide results in increased expression of NETO2 mRNA	16q12.1	A21863
Cyclophosphamide	Approved Investigational	NFE2L3	9603	downregulated	Cyclophosphamide metabolite results in decreased expression of NFE2L3 mRNA	7p15.2	A20727
Cyclophosphamide	Approved Investigational	NPRL2	10641	downregulated	Cyclophosphamide results in decreased expression of NPRL2 mRNA	3p21.31	A20660
Cyclophosphamide	Approved Investigational	NRG1	3084	upregulated	Cyclophosphamide results in increased expression of NRG1 mRNA	8p12	A21863
Cyclophosphamide	Approved Investigational	NT5C2	22978	upregulated	Cyclophosphamide results in increased expression of NT5C2 mRNA	10q24.32-q24.33	A20660
Cyclophosphamide	Approved Investigational	P2RY2	5029	downregulated	Cyclophosphamide results in decreased expression of P2RY2 mRNA	11q13.4	A21865
Cyclophosphamide	Approved Investigational	PAIP1	10605	downregulated	Cyclophosphamide results in decreased expression of PAIP1 mRNA	5p12	A20660
Cyclophosphamide	Approved Investigational	PALM2-AKAP2	445815	upregulated	Cyclophosphamide results in increased expression of PALM2-AKAP2 mRNA	9q31.3	A21865
Cyclophosphamide	Approved Investigational	PARD3	56288	downregulated	Cyclophosphamide results in decreased expression of PARD3 mRNA	10p11.22-p11.21	A20660
Cyclophosphamide	Approved Investigational	PDCD4	27250	downregulated	Cyclophosphamide results in decreased expression of PDCD4 mRNA	10q25.2	A21681
Cyclophosphamide	Approved Investigational	PELI1	57162	downregulated	Cyclophosphamide metabolite results in decreased expression of PELI1 mRNA	2p14	A20727
Cyclophosphamide	Approved Investigational	PHLDA2	7262	upregulated	Cyclophosphamide results in increased expression of PHLDA2 mRNA	11p15.4	A21865
Cyclophosphamide	Approved Investigational	PLAU	5328	upregulated	Cyclophosphamide results in increased expression of PLAU mRNA	10q22.2	A21863
Cyclophosphamide	Approved Investigational	POLM	27434	upregulated	Cyclophosphamide results in increased expression of POLM mRNA	7p13	A20660
Cyclophosphamide	Approved Investigational	PROCR	10544	upregulated	Cyclophosphamide results in increased expression of PROCR mRNA	20q11.22	A21863

Displaying entries 20751 - 20775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability